
Ottawa’s Tetra Bio-Pharma graduates to TSX
Bioscience firm that’s developing cannabinoid-based treatments for chronic pain is slated to move up from TSX Venture Exchange on Aug. 4.
Ottawa’s Tetra Bio-Pharma graduates to TSX
Bioscience firm that’s developing cannabinoid-based treatments for chronic pain is slated to move up from TSX Venture Exchange on Aug. 4.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
The Catholic Centre for Immigrants
Canadian Parks and Wilderness Society (CPAWS)
Collecting judgments may not be as easy as you think
This is your chance to contribute to the revitalization of the ByWard Market!